Clinical Trials Search

Find upcoming clinical trial events for your portfolio.

NCT IDTitleStatusPrimary Completion DatePhasesCompaniesStart DateCompletion Date
NCT06641466A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual MigraineRECRUITING2026-11-29PHASE32025-03-112027-03-30
NCT04464525Omecamtiv Mecarbil Post-trial Access StudyWITHDRAWN2026-11-27PHASE32020-12-182026-11-27
NCT06501443LATAM LOWERS LDL-CRECRUITING2026-11-27PHASE42025-02-112026-11-29
NCT07076199A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesRECRUITING2026-11-23PHASE32025-08-112026-12-28
NCT06079190Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITING2026-11-23PHASE22023-10-202026-11-23
NCT06545331Study of XB010 in Subjects With Solid TumorsRECRUITING2026-11-23PHASE12024-08-062027-10-20
NCT06052059A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)RECRUITING2026-11-21PHASE32023-10-252029-12-17
NCT06653387A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization ApproachRECRUITING2026-11-20NA2024-11-202027-11-20
NCT04640623A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical CystectomyACTIVE_NOT_RECRUITING2026-11-20PHASE22020-12-182027-07-02
NCT06623409Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).ACTIVE_NOT_RECRUITING2026-11-20PHASE12024-11-122026-11-20
NCT05983198Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLTRECRUITING2026-11-19PHASE1, PHASE22023-11-072029-11-05
NCT05946941A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeRECRUITING2026-11-18PHASE32023-09-112028-11-16
NCT06079671Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)RECRUITING2026-11-17PHASE32023-09-222029-10-18
NCT06956235Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)RECRUITING2026-11-16PHASE22025-06-092029-01-22
NCT04057352Citadel Embolization Device StudyACTIVE_NOT_RECRUITING2026-11-15NA2019-07-182026-11-15
NCT06137118AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaRECRUITING2026-11-13PHASE1, PHASE22023-12-292027-06-29
NCT04641247A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyRECRUITING2026-11-13PHASE22021-04-162026-11-13
NCT05702034A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKERECRUITING2026-11-11PHASE32023-02-152026-12-09
NCT05319730A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)RECRUITING2026-11-07PHASE1, PHASE22023-05-162029-04-10
NCT03754790Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IXACTIVE_NOT_RECRUITING2026-11-05PHASE32019-01-092026-11-05
NCT03969004Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell CarcinomaACTIVE_NOT_RECRUITING2026-11-03PHASE32019-06-042028-03-26
NCT07030517A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaRECRUITING2026-11-03PHASE42025-05-222027-06-20
NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)RECRUITING2026-11-02PHASE32025-06-132026-11-02
NCT05723562A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal CancerACTIVE_NOT_RECRUITING2026-11-02PHASE22023-04-032029-10-11
NCT05334368Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety TrialRECRUITING2026-11-02PHASE32022-09-062026-11-30
NCT06910306A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent GlioblastomaNOT_YET_RECRUITING2026-11-01NA2025-09-012026-12-01
NCT06427811Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I MutationACTIVE_NOT_RECRUITING2026-11-01PHASE42024-11-282026-11-01
NCT06951698A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I DisorderRECRUITING2026-11-01PHASE32025-06-112026-11-01
NCT05626855Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabACTIVE_NOT_RECRUITING2026-11-01PHASE32023-04-172029-05-02
NCT06846320Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderRECRUITING2026-11PHASE22025-04-292026-11
NCT06723236A Study of MGC028 in Participants With Advanced Solid TumorsRECRUITING2026-11PHASE12025-02-132027-04
NCT06284954A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With DermatomyositisACTIVE_NOT_RECRUITING2026-11PHASE22024-08-202026-11
NCT04064827A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)ACTIVE_NOT_RECRUITING2026-11PHASE32020-09-162027-03
NCT06395948A Study Evaluating APG777 in Atopic DermatitisRECRUITING2026-11PHASE22024-04-292028-06
NCT06362265A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes MellitusRECRUITING2026-11PHASE12024-10-102026-11
NCT06361836Study of Single Doses of SBT777101 in Subjects With Hidradenitis SuppurativaRECRUITING2026-11PHASE12024-10-092026-11
NCT06982859A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes MellitusRECRUITING2026-11PHASE12025-06-022026-11
NCT07003919Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)RECRUITING2026-11PHASE32025-06-242028-05
NCT06891716[18F]ACI-19626 PET in TDP-43 ProteinopathiesRECRUITING2026-11EARLY_PHASE12025-01-212026-11
NCT05362773A Study of MGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesRECRUITING2026-11PHASE12022-07-132027-05
NCT05822752Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)ACTIVE_NOT_RECRUITING2026-11PHASE22023-09-212026-11
NCT04396236A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineRECRUITING2026-11PHASE32020-06-152026-11
NCT06561048Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaRECRUITING2026-11PHASE32024-10-022028-07
NCT06672055A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionRECRUITING2026-11PHASE22024-10-082026-11
NCT07142811A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionRECRUITING2026-11PHASE22025-08-052031-04
NCT05607004(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerRECRUITING2026-11PHASE22023-02-142027-04
NCT05456685Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian CancerACTIVE_NOT_RECRUITING2026-11PHASE22022-09-282026-11
NCT06649045A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or OverweightACTIVE_NOT_RECRUITING2026-11PHASE32024-10-222027-01
NCT05879744A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)ACTIVE_NOT_RECRUITING2026-11PHASE12023-05-312027-04
NCT06854952A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or ObesityACTIVE_NOT_RECRUITING2026-11PHASE22025-03-072026-12
NCT06825702Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular EdemaRECRUITING2026-11PHASE22025-05-012026-12
NCT04486378A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal CancerRECRUITING2026-11PHASE22021-03-082030-08
NCT05726864A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsACTIVE_NOT_RECRUITING2026-11PHASE1, PHASE22023-04-142026-11
NCT04895436Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)RECRUITING2026-11PHASE22022-03-282029-01
NCT06082960Study of GS-9911 With or Without Antibody Treatment for Adults With Solid TumorsACTIVE_NOT_RECRUITING2026-11PHASE12023-10-092026-11
NCT07004907Efficacy and Tolerability of the APD Treatment in PAED PatientsNOT_YET_RECRUITING2026-11NA2026-012026-11
NCT07036835Clinical Investigation of a Femtosecond Laser for Corneal Flap CreationRECRUITING2026-11NA2025-08-272026-11
NCT06106308Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationACTIVE_NOT_RECRUITING2026-11PHASE22024-02-272027-01
NCT06422351Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase DeficiencyNOT_YET_RECRUITING2026-11PHASE22024-082029-01
NCT07108894A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy ParticipantsRECRUITING2026-11EARLY_PHASE12025-07-252026-11
NCT06120075A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced MalignanciesRECRUITING2026-11PHASE12024-01-192026-11
NCT05202509Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular DiseaseACTIVE_NOT_RECRUITING2026-11PHASE32022-02-072026-11
NCT06506903Avalus Ultra Post-Approval Study (PAS)RECRUITING2026-11NA2024-11-202026-11
NCT06742801Onyxâ„¢ Liquid Embolic IDE Clinical StudyRECRUITING2026-11NA2025-05-092026-12
NCT06226883A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRECRUITING2026-11PHASE22024-07-182028-08
NCT05544552Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene AlterationsRECRUITING2026-11PHASE1, PHASE22022-11-222027-06
NCT05648500A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus ErythematosusRECRUITING2026-10-31PHASE32022-12-132027-05-01
NCT04336241Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsRECRUITING2026-10-31PHASE12019-10-172028-04-30
NCT06463340Study of SGR-3515 In Participants With Advanced Solid Tumors.RECRUITING2026-10-31PHASE12024-06-182026-12-31
NCT06635447Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsRECRUITING2026-10-31PHASE32024-09-262026-10-31
NCT05405595ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid TumorsRECRUITING2026-10-31PHASE1, PHASE22022-06-152027-04-30
NCT07148414A Study of SPY072 in Rheumatic DiseaseRECRUITING2026-10-31PHASE22025-08-212028-03-31
NCT06103864A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast CancerRECRUITING2026-10-31PHASE32023-11-232029-04-30
NCT05067868A Study of Replagal in Children and Adults With Fabry Disease in IndiaRECRUITING2026-10-31PHASE42022-11-012026-11-30
NCT05672576A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusRECRUITING2026-10-31PHASE32023-06-262027-05-01
NCT03992430A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)ACTIVE_NOT_RECRUITING2026-10-31PHASE32020-07-132026-10-31
NCT06429761Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian PatientsRECRUITING2026-10-31PHASE42025-01-022026-10-31
NCT02716116A Study of TAK-788 in Adults With Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-10-31PHASE1, PHASE22016-06-162026-10-31
NCT06507904A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy AdultsNOT_YET_RECRUITING2026-10-31PHASE12026-04-172026-10-31
NCT05548296A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaRECRUITING2026-10-31PHASE22022-08-292027-04-30
NCT06510816A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)RECRUITING2026-10-31PHASE32024-07-302027-10-31
NCT04129502TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsACTIVE_NOT_RECRUITING2026-10-31PHASE32020-01-102026-10-31
NCT05444257A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination TherapyACTIVE_NOT_RECRUITING2026-10-30PHASE32022-11-082026-10-30
NCT02843035Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionACTIVE_NOT_RECRUITING2026-10-30PHASE22017-01-042026-10-30
NCT04970901A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)RECRUITING2026-10-30PHASE12022-06-172027-10-29
NCT06531798Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary DiseaseNOT_YET_RECRUITING2026-10-30PHASE42025-10-302027-12-30
NCT04198766Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RECRUITING2026-10-30PHASE1, PHASE22019-12-102027-05-12
NCT06471257A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With AsthmaRECRUITING2026-10-30PHASE32024-06-172026-10-30
NCT04736706A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)ACTIVE_NOT_RECRUITING2026-10-29PHASE32021-04-142026-10-29
NCT06696755A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderNOT_YET_RECRUITING2026-10-29PHASE22025-05-152026-10-29
NCT05239728A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)ACTIVE_NOT_RECRUITING2026-10-28PHASE32022-03-152029-09-28
NCT05263934Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)RECRUITING2026-10-27PHASE32022-07-142026-11-24
NCT05360446Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular EventsACTIVE_NOT_RECRUITING2026-10-26PHASE32022-07-082026-10-26
NCT06003426A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisACTIVE_NOT_RECRUITING2026-10-26PHASE32023-09-142026-10-26
NCT07086664A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of MalnutritionRECRUITING2026-10-25PHASE12025-08-052026-10-25
NCT06516952A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)RECRUITING2026-10-25PHASE32024-10-102027-06-02
NCT07018596NS-PFA Catheter Ablation of Paroxysmal and Persistent Atrial Fibrillation With the Pulse Biosciences CellFX SystemNOT_YET_RECRUITING2026-10-25NA2025-08-252027-01-25
NCT06040099A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARERECRUITING2026-10-23PHASE22024-02-132026-10-23
NCT05030506A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)ACTIVE_NOT_RECRUITING2026-10-21PHASE12021-10-132026-10-21
NCT05531565A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusRECRUITING2026-10-20PHASE2, PHASE32022-09-132027-12-14
NCT06346392AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2RECRUITING2026-10-19PHASE32024-03-042027-04-19
NCT05567185A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder CancerACTIVE_NOT_RECRUITING2026-10-16PHASE12023-03-032027-09-24
NCT03368742Microdystrophin Gene Transfer Study in Adolescents and Children With DMDACTIVE_NOT_RECRUITING2026-10-15PHASE1, PHASE22017-12-062026-10-15
NCT06517875Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent MyelofibrosisRECRUITING2026-10-14PHASE22025-02-282026-11-13
NCT05372354A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaRECRUITING2026-10-12PHASE1, PHASE22022-10-182026-10-12
NCT06995820A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.RECRUITING2026-10-12PHASE12025-06-062026-10-12
NCT06616974A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)RECRUITING2026-10-09PHASE22024-10-082026-11-20
NCT06959225Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)RECRUITING2026-10-09PHASE32025-06-232027-07-11
NCT06749457A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)RECRUITING2026-10-09PHASE1, PHASE22024-12-302027-07-06
NCT05925803Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)RECRUITING2026-10-09PHASE32023-11-082027-12-31
NCT06958211Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)RECRUITING2026-10-09PHASE32025-06-122027-07-11
NCT06616194A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigraineRECRUITING2026-10-08PHASE32024-11-152027-12-02
NCT05136677A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese ParticipantsACTIVE_NOT_RECRUITING2026-10-07PHASE22022-01-252026-10-08
NCT05831111A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsACTIVE_NOT_RECRUITING2026-10-07PHASE12023-04-052026-10-07
NCT02612454Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)ACTIVE_NOT_RECRUITING2026-10-07PHASE32015-10-152026-10-07
NCT06512883A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesRECRUITING2026-10-06PHASE32025-04-172027-12-29
NCT06200207A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationRECRUITING2026-10-05PHASE32024-04-012027-01-12
NCT05164094A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and AdultsACTIVE_NOT_RECRUITING2026-10-05PHASE1, PHASE22021-12-282026-10-05
NCT06713369AZD5305 hADME in Patients With Advanced Solid MalignanciesRECRUITING2026-10-02PHASE12025-04-022026-10-02
NCT07098806Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesRECRUITING2026-10-02PHASE12025-07-022031-10-02
NCT04812925A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients with Primary Immune ThrombocytopeniaACTIVE_NOT_RECRUITING2026-10-01PHASE32021-11-172026-10-01
NCT05642455SPEARHEAD-3 Pediatric StudyRECRUITING2026-10-01PHASE1, PHASE22023-09-012038-07-30
NCT06151964A Trial to Learn How Safe AZD9550 is in People With or Without Type 2 Diabetes Who Are Overweight or ObeseACTIVE_NOT_RECRUITING2026-10-01PHASE1, PHASE22023-09-292026-10-01
NCT05230537A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationACTIVE_NOT_RECRUITING2026-10-01PHASE22022-02-172026-10-02
NCT05908084To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisRECRUITING2026-10PHASE32023-09-072027-10
NCT06560632Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-10PHASE12024-09-172028-12
NCT06727552A Study of Barzolvolimab in Patients With Atopic DermatitisRECRUITING2026-10PHASE22025-01-072027-05
NCT06842186A Phase 1 Study of WVE-007 in Adults Living with Overweight or ObesityRECRUITING2026-10PHASE12025-01-312026-10
NCT06698458Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerRECRUITING2026-10NA2025-06-172026-12
NCT06445023A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaRECRUITING2026-10PHASE32024-07-112027-04
NCT06119581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRECRUITING2026-10PHASE32023-12-212029-10
NCT05983250LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFRECRUITING2026-10PHASE32024-01-102028-10
NCT06895343A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous Doses of ABBV-701 in Healthy Adult Western and Asian ParticipantsRECRUITING2026-10PHASE12025-04-032026-10
NCT06603324Analysis of Paediatric Treatments With multiFiltratePRONOT_YET_RECRUITING2026-10NA2025-102026-12
NCT05787587A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsRECRUITING2026-10PHASE12023-04-052027-05
NCT06325566Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainRECRUITING2026-10PHASE32024-07-032027-10
NCT04777994Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsRECRUITING2026-10PHASE12021-03-092026-10
NCT06857942A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RECRUITING2026-10PHASE42025-03-192026-10
NCT05432583A Clinical Trial in Healthy Volunteers and Volunteers with Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination with an Investigational Vaccine Designed to Prevent Genital Herpes LesionsRECRUITING2026-10PHASE12022-12-082026-10
NCT07152002A Study of LY4064912 in Healthy Participants and With Overweight or ObesityRECRUITING2026-10PHASE12025-08-282026-10
NCT07059312A Phase 1 Study of JADE101 in Healthy ParticipantsRECRUITING2026-10PHASE12025-08-172026-10
NCT07046494Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderRECRUITING2026-10PHASE22025-07-252026-12
NCT06455202A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)RECRUITING2026-10PHASE32024-07-192027-04
NCT05395481A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RECRUITING2026-10PHASE12022-06-082026-10
NCT07161635Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLsNOT_YET_RECRUITING2026-10NA2025-102026-10
NCT06897358Leniolisib for Immune Dysregulation in CVIDRECRUITING2026-10PHASE22025-02-122026-10
NCT05407636Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDRECRUITING2026-10PHASE32022-01-132027-11
NCT06798896RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset SeizuresRECRUITING2026-10PHASE22024-12-302026-10
NCT06107413Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabRECRUITING2026-10PHASE22023-11-122026-10
NCT06338995A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)RECRUITING2026-10PHASE32024-04-292027-02
NCT05747924Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)ACTIVE_NOT_RECRUITING2026-10PHASE1, PHASE22023-04-042027-04
NCT07090161Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionNOT_YET_RECRUITING2026-10PHASE22025-07-282026-11
NCT06910358Study of Bitopertin in Participants With EPP or XLP (APOLLO)RECRUITING2026-10PHASE32025-04-042026-11
NCT06553768Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)RECRUITING2026-10PHASE32024-10-142027-02
NCT06560645A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationRECRUITING2026-10PHASE12024-11-042027-04
NCT07054281UNITY VCS Vitreoretinal SurgeryNOT_YET_RECRUITING2026-10NA2026-012027-02
NCT07027527An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic DermatitisRECRUITING2026-10PHASE12025-06-042027-10
NCT06173505Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLCRECRUITING2026-10PHASE1, PHASE22023-12-272027-10
NCT06683742A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56ACTIVE_NOT_RECRUITING2026-10PHASE32024-11-272027-10
NCT06335173A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)ACTIVE_NOT_RECRUITING2026-10PHASE22024-02-292026-10
NCT05804669A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromeRECRUITING2026-10PHASE1, PHASE22023-10-122026-10
NCT07155031Biotin-Acridine Red Cell Exchange KineticsNOT_YET_RECRUITING2026-09-30PHASE22025-10-152026-12-15
NCT04961567A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusRECRUITING2026-09-30PHASE32021-07-162027-03-16
NCT05138133Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisRECRUITING2026-09-30PHASE32022-02-152028-07-07
NCT07025304Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in ChinaRECRUITING2026-09-30NA2025-07-022028-06-30
NCT06987513RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or OverweightRECRUITING2026-09-30PHASE22025-05-152026-09-30
NCT06534892An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 StudyRECRUITING2026-09-30PHASE32024-08-012026-09-30
NCT04039607A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular CarcinomaACTIVE_NOT_RECRUITING2026-09-30PHASE32019-09-302026-09-30
NCT06716853A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients Suffering from Metastatic Renal Cell CarcinomaRECRUITING2026-09-30PHASE1, PHASE22024-10-222026-09-30
NCT05059522Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingACTIVE_NOT_RECRUITING2026-09-30PHASE32021-09-292026-09-30
NCT05318105Ultrafiltration Versus IV Diuretics in Worsening Heart FailureRECRUITING2026-09-30NA2022-06-282026-12-31
NCT06280209A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular DystrophyRECRUITING2026-09-30PHASE1, PHASE22024-01-032026-09-30
NCT05827614Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsRECRUITING2026-09-30PHASE12023-03-242027-03-31
NCT06392386A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia GravisRECRUITING2026-09-30PHASE2, PHASE32024-06-282026-09-30
NCT06484114Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on TirzepatideACTIVE_NOT_RECRUITING2026-09-30NA2024-09-012027-09-30
NCT05888831A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-09-30PHASE1, PHASE22023-06-062026-09-30
NCT06254950A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisRECRUITING2026-09-30PHASE22024-03-292027-08-04
NCT04895241A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusRECRUITING2026-09-30PHASE32021-05-252027-03-16
NCT06100276Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)RECRUITING2026-09-30PHASE1, PHASE22024-08-012031-03-30
NCT06948773A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)RECRUITING2026-09-30NA2025-05-212026-09-30
NCT05896163A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.RECRUITING2026-09-28PHASE1, PHASE22023-08-302028-09-27
NCT05956626A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseRECRUITING2026-09-28PHASE2, PHASE32023-08-252026-09-28
NCT07143604A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2RECRUITING2026-09-28PHASE22025-08-292027-09-28
NCT05017012A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)ACTIVE_NOT_RECRUITING2026-09-26PHASE12021-09-212026-09-26
NCT05484206Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434RECRUITING2026-09-25PHASE12022-09-212027-04-30
NCT06951880A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersNOT_YET_RECRUITING2026-09-24PHASE12025-06-272026-09-24
NCT04557449Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsACTIVE_NOT_RECRUITING2026-09-23PHASE22020-09-232027-11-23
NCT05995964A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisRECRUITING2026-09-21PHASE22023-08-222026-12-14
NCT06660563A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)RECRUITING2026-09-21PHASE12024-10-222026-09-21
NCT06708299CardiolRx in Recurrent Pericarditis Following IL-1 Blocker CessationRECRUITING2026-09-21PHASE32025-04-072026-10-21
NCT06465186A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)RECRUITING2026-09-21PHASE22024-07-122026-09-21
NCT06613100Evaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerRECRUITING2026-09-19PHASE12024-11-252030-01-23
NCT06145373A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With EmicizumabRECRUITING2026-09-19PHASE42024-03-012029-11-30
NCT03162536A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)ACTIVE_NOT_RECRUITING2026-09-18PHASE1, PHASE22017-06-262026-09-18
NCT06233461A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseRECRUITING2026-09-18PHASE22024-03-052027-07-23
NCT07204964A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and AboveNOT_YET_RECRUITING2026-09-18PHASE22025-10-102026-09-18
NCT06671587iGlarLixi CGM Study in Chinese T2D Individuals After OADsRECRUITING2026-09-18PHASE42024-12-102026-09-18
NCT06082037A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionRECRUITING2026-09-17PHASE32023-10-102028-06-02
NCT06832410An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantRECRUITING2026-09-17PHASE32025-03-312027-09-17
NCT03423628A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerRECRUITING2026-09-16PHASE12018-04-022026-09-16
NCT06807463A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseRECRUITING2026-09-15PHASE22025-03-312027-09-14
NCT04634877Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)ACTIVE_NOT_RECRUITING2026-09-15PHASE32021-01-102026-09-15
NCT05038735Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.ACTIVE_NOT_RECRUITING2026-09-15PHASE32021-12-172026-10-15
NCT06449378Transorbâ„¢ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral HerniaACTIVE_NOT_RECRUITING2026-09-15NA2024-07-022030-10-01
NCT05721222Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)RECRUITING2026-09-15PHASE1, PHASE22023-03-152026-12-31
NCT06637371A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaRECRUITING2026-09-13PHASE12024-10-162026-10-25
NCT05662319A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe HemophiliaACTIVE_NOT_RECRUITING2026-09-12PHASE32023-02-012028-06-01
NCT07087795A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesRECRUITING2026-09-12PHASE12025-07-012026-09-25
NCT07153159A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding WomenRECRUITING2026-09-12PHASE12025-08-072026-10-12
NCT06516965A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)RECRUITING2026-09-11PHASE32024-10-102027-06-02
NCT05521087A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWITHDRAWN2026-09-11PHASE12025-12-262030-01-29
NCT05469360Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease ParticipantsRECRUITING2026-09-11PHASE12023-02-232028-01-02
NCT06079879A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)RECRUITING2026-09-10PHASE32023-12-312028-08-18
NCT05093972Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)NOT_YET_RECRUITING2026-09-10PHASE12026-04-072026-09-10
NCT03953300Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsRECRUITING2026-09-09PHASE42019-10-172026-09-09
NCT05798117An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusACTIVE_NOT_RECRUITING2026-09-09PHASE1, PHASE22023-02-282026-09-09
NCT06006559A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue FeverRECRUITING2026-09-07PHASE22024-02-202026-09-07
NCT05754957A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeRECRUITING2026-09-07PHASE32023-04-072026-12-09
NCT06730750A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsRECRUITING2026-09-05PHASE1, PHASE22025-02-122029-12-09
NCT04857372A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid TumorsACTIVE_NOT_RECRUITING2026-09-04PHASE12021-10-212026-09-04
NCT06734234A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney DiseaseRECRUITING2026-09-04PHASE12024-12-112026-09-04
NCT06118281ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackRECRUITING2026-09-03PHASE32024-06-252026-09-03
NCT07099898A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)RECRUITING2026-09-02PHASE32025-08-112028-09-11
NCT06245408A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom StateRECRUITING2026-09-02PHASE32024-04-082026-11-03
NCT04824092Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL PatientsACTIVE_NOT_RECRUITING2026-09-01PHASE32021-05-112027-11-01
NCT06717698A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRECRUITING2026-09-01PHASE22024-12-022026-09-29
NCT06132256MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)RECRUITING2026-09PHASE22023-12-112026-11
NCT06307626A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.RECRUITING2026-09PHASE32024-03-282027-09
NCT06381141A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple MyelomaACTIVE_NOT_RECRUITING2026-09PHASE12024-09-032027-03
NCT05303064Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderRECRUITING2026-09PHASE32022-06-302026-09
NCT05172726Tapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsRECRUITING2026-09PHASE32021-12-022026-09
NCT06143956A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRECRUITING2026-09PHASE22023-11-172026-11
NCT06150183Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid TumorsRECRUITING2026-09PHASE12023-11-302026-09
NCT06568692A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerRECRUITING2026-09PHASE22024-10-022026-10
NCT06793371AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFRECRUITING2026-09PHASE22025-02-062026-09
NCT05536804A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesACTIVE_NOT_RECRUITING2026-09PHASE22023-02-082026-10
NCT02736656Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)ACTIVE_NOT_RECRUITING2026-09PHASE32016-02-022026-09
NCT06993610Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseRECRUITING2026-09PHASE22025-05-162027-03
NCT06138743Study of ARO-DM1 in Subjects With Type 1 Myotonic DystrophyRECRUITING2026-09PHASE1, PHASE22024-03-042026-09
NCT06742190A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor NeuropathyRECRUITING2026-09PHASE32024-12-182029-12
NCT06297603Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)RECRUITING2026-09PHASE32024-03-152026-10
NCT06868264C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVRECRUITING2026-09PHASE32025-04-072026-12
NCT06569823Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy AdultsRECRUITING2026-09PHASE1, PHASE22024-06-172026-09
NCT06307613A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye DiseaseRECRUITING2026-09PHASE32024-03-272027-09
NCT07169851A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerNOT_YET_RECRUITING2026-09PHASE22025-102026-09
NCT05459181HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)NOT_YET_RECRUITING2026-09NA2025-122026-09
NCT07090330ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisRECRUITING2026-09PHASE22025-07-182027-05
NCT07024693DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyRECRUITING2026-09PHASE22025-072026-12
NCT07179055An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeRECRUITING2026-09PHASE22025-102026-09
NCT06405633A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATDRECRUITING2026-09PHASE1, PHASE22024-07-192026-09
NCT06812325A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)RECRUITING2026-09PHASE32025-02-032026-12
NCT06830629A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseRECRUITING2026-09PHASE22025-02-052026-09
NCT06920901A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With AsthmaACTIVE_NOT_RECRUITING2026-09PHASE12025-03-272027-03
NCT05315700Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationRECRUITING2026-09PHASE1, PHASE22022-03-102027-09
NCT06100744A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRECRUITING2026-09PHASE32024-07-082028-10
NCT04562870A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated MyelofibrosisACTIVE_NOT_RECRUITING2026-09PHASE22021-03-172026-09
NCT06334133Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesRECRUITING2026-09PHASE32024-06-142026-10
NCT07020923Monthly Dosing of Atacicept in IgANRECRUITING2026-09PHASE22025-05-292027-09
NCT06095986A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing CholangitisWITHDRAWN2026-09PHASE22025-062027-12
NCT06160752Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene AlterationsRECRUITING2026-09PHASE12023-11-222027-09
NCT05848011A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerACTIVE_NOT_RECRUITING2026-09PHASE22023-09-282027-09
NCT05106491Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock PatientsNOT_YET_RECRUITING2026-09NA2025-092026-09
NCT06108219A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)ACTIVE_NOT_RECRUITING2026-09PHASE22023-10-252026-09
NCT05320198Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaRECRUITING2026-09PHASE1, PHASE22022-06-062026-09
NCT05592002Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.ACTIVE_NOT_RECRUITING2026-09NA2022-12-282028-09
NCT03845166A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsACTIVE_NOT_RECRUITING2026-08-31PHASE12019-03-202027-05-31
NCT05669482Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerACTIVE_NOT_RECRUITING2026-08-31PHASE1, PHASE22023-03-222027-08-31
NCT05107674A Study of NX-1607 in Adults With Advanced MalignanciesRECRUITING2026-08-31PHASE12021-09-292028-02-28
NCT06550895A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple MyelomaRECRUITING2026-08-31PHASE22024-09-162026-08-31
NCT05567406Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic TherapyRECRUITING2026-08-31PHASE22025-06-162026-08-31
NCT05743881A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 MonthsACTIVE_NOT_RECRUITING2026-08-31PHASE12023-02-152026-09-30
NCT02934568Ribociclib (LEE011) Rollover Study for Continued AccessRECRUITING2026-08-31PHASE22016-12-152026-09-01
NCT05884398A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCACTIVE_NOT_RECRUITING2026-08-31PHASE32023-08-312026-08-31
NCT06152575MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)RECRUITING2026-08-30PHASE32024-02-082027-12-30
NCT05739981Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal CancerRECRUITING2026-08-30PHASE1, PHASE22023-02-102028-01-30
NCT07047521A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsNOT_YET_RECRUITING2026-08-30PHASE32025-11-172027-07-30
NCT07161414A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyNOT_YET_RECRUITING2026-08-27PHASE12025-10-212028-03-28
NCT05757713Teplizumab in Pediatric Stage 2 Type 1 DiabetesACTIVE_NOT_RECRUITING2026-08-27PHASE42023-07-252026-08-27
NCT04699188Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationACTIVE_NOT_RECRUITING2026-08-26PHASE1, PHASE22021-02-242026-08-26
NCT07160257A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes MellitusRECRUITING2026-08-26PHASE12025-08-052026-12-13
NCT07211607I.V. Selonabant in Healthy Adult SubjectsRECRUITING2026-08-25PHASE12025-09-222026-08-25
NCT06984627A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseRECRUITING2026-08-25PHASE22025-09-022026-09-23
NCT04711252A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseACTIVE_NOT_RECRUITING2026-08-24PHASE32021-01-282029-02-01
NCT05262400A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsACTIVE_NOT_RECRUITING2026-08-23PHASE1, PHASE22022-03-142026-08-23
NCT06797869A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyRECRUITING2026-08-21PHASE22025-01-292026-08-21
NCT04626635A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersRECRUITING2026-08-19PHASE1, PHASE22020-12-212026-12-12
NCT05489211Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)RECRUITING2026-08-19PHASE22022-09-062026-08-19
NCT06659640A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)RECRUITING2026-08-19PHASE1, PHASE22024-11-112028-06-22
NCT05298423Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)ACTIVE_NOT_RECRUITING2026-08-19PHASE32022-05-032026-08-19
NCT04995523A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCRECRUITING2026-08-18PHASE1, PHASE22021-09-142028-03-16
NCT06655155A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisRECRUITING2026-08-17PHASE22024-11-112027-06-14
NCT05639647Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative InfectionsRECRUITING2026-08-17PHASE22023-04-182026-08-17
NCT03974113Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BACTIVE_NOT_RECRUITING2026-08-15PHASE32020-01-282026-12-15
NCT05444465Use of the REGENETENâ„¢ Bioinductive Implant System in High Grade Partial-thickness TearsRECRUITING2026-08-15NA2022-08-302028-06-30
NCT06433921A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 InclusiveRECRUITING2026-08-14PHASE12024-08-142026-08-14
NCT05267613Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.RECRUITING2026-08-14PHASE32022-07-012027-09-06
NCT06432764Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.RECRUITING2026-08-14PHASE12024-10-162026-08-14
NCT05168748CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic LeukemiaWITHDRAWN2026-08-13PHASE12023-01-242026-08-13
NCT05601752ADP-A2M4CD8 Monotherapy and in Combination with Nivolumab in HLA-A2+ Subjects with MAGE-A4 Positive Ovarian Cancer (SURPASS-3)ACTIVE_NOT_RECRUITING2026-08-12PHASE22023-06-262026-08-12
NCT06667141Phase 1 Study of ACR-2316 in Specific Advanced Solid TumorsRECRUITING2026-08-12PHASE12024-10-082026-12-12
NCT06147856A Dose-finding Study to Evaluate mRNA-3210 in Participants With PhenylketonuriaWITHDRAWN2026-08-10PHASE1, PHASE22024-03-292027-08-05
NCT06376045A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaRECRUITING2026-08-10PHASE22024-05-242026-10-02
NCT06548360A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental VitiligoRECRUITING2026-08-10PHASE32025-01-242027-03-13
NCT05508906Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, or Everolimus in ER+, HER2- Breast CancerACTIVE_NOT_RECRUITING2026-08-09PHASE12022-08-312026-09-09
NCT07103148A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationRECRUITING2026-08-08PHASE32025-07-112029-10-11
NCT06691113A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal PolypsRECRUITING2026-08-07PHASE22024-12-162027-02-09
NCT07017179This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/OverweightRECRUITING2026-08-06PHASE22025-05-202026-08-06
NCT07133828A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years OldRECRUITING2026-08-06PHASE12025-08-292026-08-06
NCT07112339A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesRECRUITING2026-08-04PHASE42025-08-152028-08-31
NCT04133636A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple MyelomaRECRUITING2026-08-04PHASE22019-11-072028-01-17
NCT06557772A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac DiseaseRECRUITING2026-08-04PHASE22024-08-292029-04-10
NCT04929210A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseRECRUITING2026-08-04PHASE42021-08-302027-04-13
NCT06855160A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of AgeRECRUITING2026-08-03PHASE32025-04-172026-12-24
NCT07205159A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.NOT_YET_RECRUITING2026-08-03PHASE12025-10-152026-12-12
NCT05577182Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced MalignanciesACTIVE_NOT_RECRUITING2026-08-03PHASE12023-01-052026-08-03
NCT05920135First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKIACTIVE_NOT_RECRUITING2026-08-01PHASE1, PHASE22023-09-112028-08-01
NCT05683457A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.RECRUITING2026-08-01PHASE22023-04-052026-08-01
NCT04899310A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic AcidemiaRECRUITING2026-08-01PHASE1, PHASE22021-08-062028-08-01
NCT06418711ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionRECRUITING2026-08-01PHASE32024-09-112028-12-01
NCT06455059Interventional Study of Vosoritide for the Treatment of Children with HypochondroplasiaENROLLING_BY_INVITATION2026-08-01PHASE32024-06-062026-08-01
NCT06727565Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma.RECRUITING2026-08PHASE22025-02-182026-08
NCT01983241Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)ACTIVE_NOT_RECRUITING2026-08PHASE32013-112027-01
NCT02099058A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-08PHASE12014-01-152026-08
NCT05517447Extension Study to Assess Batoclimab in Participants With Thyroid Eye DiseaseRECRUITING2026-08PHASE32022-11-062026-08
NCT06668064A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56ACTIVE_NOT_RECRUITING2026-08PHASE32024-10-222027-08
NCT06669754Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAERECRUITING2026-08PHASE32024-12-012026-08
NCT03539744A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.ACTIVE_NOT_RECRUITING2026-08PHASE32018-10-222027-11
NCT07021547A Study of LY3867070 in Healthy ParticipantsRECRUITING2026-08PHASE12025-05-272026-08
NCT06667453A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1RECRUITING2026-08PHASE22024-12-102026-08
NCT07032597A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult ParticipantsACTIVE_NOT_RECRUITING2026-08PHASE32025-05-262026-10
NCT07011966ASV Therapy for InsomniaNOT_YET_RECRUITING2026-08NA2025-082026-08
NCT06050122Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeACTIVE_NOT_RECRUITING2026-08PHASE32024-03-172026-08
NCT06001788Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRECRUITING2026-08PHASE12024-02-222027-08
NCT06389136A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRECRUITING2026-08PHASE32024-06-122027-03
NCT06579300A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088SUSPENDED2026-08PHASE12024-09-042026-08
NCT05211570AB8939 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRECRUITING2026-08PHASE1, PHASE22022-06-012026-12
NCT06909214A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)RECRUITING2026-08PHASE42025-04-172027-05
NCT05995340ELAPR002f Injectable Gel in the Treatment of Atrophic Acne ScarsACTIVE_NOT_RECRUITING2026-08PHASE32023-11-212026-08
NCT07122583A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite SystemRECRUITING2026-08PHASE42025-07-222026-08
NCT05580562ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)RECRUITING2026-08PHASE32023-01-232026-08
NCT06260722Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)ACTIVE_NOT_RECRUITING2026-08PHASE32024-02-212027-01
NCT06775379A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderRECRUITING2026-08PHASE32024-12-202026-10
NCT07108036A Study to Assess Anktiva in Patients With Long Covid-19.NOT_YET_RECRUITING2026-08PHASE22025-082026-08
NCT06656416ALTO-100 in Bipolar Disorder With Depression (BD-D)RECRUITING2026-08PHASE22024-10-022026-10
NCT03328078CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)RECRUITING2026-08PHASE1, PHASE22017-12-282026-10
NCT06600724Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUsRECRUITING2026-08NA2024-08-272026-08
NCT06817356A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderRECRUITING2026-08PHASE22025-02-062026-08
NCT05291091Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)ACTIVE_NOT_RECRUITING2026-08PHASE22022-07-062026-08
NCT07165002A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver ImpairmentNOT_YET_RECRUITING2026-08PHASE12025-102026-08
NCT05611931Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaRECRUITING2026-08PHASE32023-04-182028-01
NCT05308264Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)RECRUITING2026-08PHASE1, PHASE22022-09-122026-12
NCT07011706ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisRECRUITING2026-08PHASE22025-05-302026-10
NCT06906341Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerRECRUITING2026-08PHASE22025-04-112026-12
NCT07186595A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial AppearanceNOT_YET_RECRUITING2026-08PHASE42025-09-232026-08
NCT05802329Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)RECRUITING2026-07-31PHASE12024-01-132026-07-31
NCT06639828Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver ImagingRECRUITING2026-07-31PHASE42025-01-202026-10-31
NCT07038473Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)NOT_YET_RECRUITING2026-07-31NA2025-08-312026-09-01
NCT05382325A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)ACTIVE_NOT_RECRUITING2026-07-31PHASE12022-06-162026-07-31
NCT05025605Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar DisorderRECRUITING2026-07-31PHASE12021-08-272026-12-31
NCT06942910A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High ProteinuriaRECRUITING2026-07-31PHASE22025-05-072026-07-31
NCT04729907A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)ACTIVE_NOT_RECRUITING2026-07-31PHASE32021-04-192026-07-31
NCT04379596Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)RECRUITING2026-07-30PHASE22020-06-032026-07-30
NCT04433065TTVR Early Feasibility StudyRECRUITING2026-07-30NA2020-10-202031-07-30
NCT06669234Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy AdultsRECRUITING2026-07-30PHASE12025-03-062026-07-30
NCT06953466Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITING2026-07-30PHASE2, PHASE32025-072026-07-30
NCT07015437A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1NOT_YET_RECRUITING2026-07-30PHASE22025-07-152026-10-15
NCT06067230A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsACTIVE_NOT_RECRUITING2026-07-30PHASE32023-10-062026-07-30
NCT05261139EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseaseRECRUITING2026-07-30PHASE32022-03-072026-07-30
NCT06908304A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCNOT_YET_RECRUITING2026-07-29PHASE32025-11-032027-07-29
NCT05895786A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]RECRUITING2026-07-28PHASE32023-05-202026-07-28
NCT06551142A Study of GSK5764227 in Participants With Advanced Solid TumorsRECRUITING2026-07-27PHASE12024-09-302027-03-19
NCT06291857A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineACTIVE_NOT_RECRUITING2026-07-26PHASE32024-12-092026-09-30
NCT04036435Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisACTIVE_NOT_RECRUITING2026-07-25PHASE32019-08-122026-07-26
NCT06629779A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.RECRUITING2026-07-24PHASE32024-10-222028-11-30
NCT05412030A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsACTIVE_NOT_RECRUITING2026-07-23PHASE22022-06-162026-07-23
NCT06630117A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)RECRUITING2026-07-23PHASE12024-03-012027-01-25
NCT06608901A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced HypotensionRECRUITING2026-07-23PHASE22025-05-052026-10-19
NCT04123366Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)ACTIVE_NOT_RECRUITING2026-07-23PHASE22019-11-182026-07-23
NCT05879822A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveACTIVE_NOT_RECRUITING2026-07-22PHASE22023-10-302026-07-22
NCT06585462Single and Multiple Ascending Dose Study of AMG 513 in Participants With ObesityRECRUITING2026-07-22PHASE12024-09-092026-07-22
NCT07029568A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy PeopleRECRUITING2026-07-22PHASE12025-06-132026-07-22
NCT04846920A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)ACTIVE_NOT_RECRUITING2026-07-21PHASE12021-06-142026-07-21
NCT05468697A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)ACTIVE_NOT_RECRUITING2026-07-21PHASE1, PHASE22022-08-102026-07-21
NCT06899061Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of SaruparibRECRUITING2026-07-21PHASE12025-03-252026-11-19
NCT06058156Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisACTIVE_NOT_RECRUITING2026-07-21PHASE22023-11-092026-08-18
NCT05316220A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative ColitisWITHDRAWN2026-07-19PHASE32025-09-152026-07-19
NCT06052267A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsRECRUITING2026-07-17PHASE32023-08-302026-07-17
NCT06385080A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck CancerRECRUITING2026-07-17PHASE1, PHASE22024-04-222028-04-17
NCT07049328HCW9302 (Interleukin-2 Fusion Protein) for Alopecia AreataRECRUITING2026-07-16PHASE12025-08-162026-12-15
NCT05583227Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisACTIVE_NOT_RECRUITING2026-07-16PHASE32022-11-102027-03-25
NCT06539481Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.RECRUITING2026-07-15PHASE42024-08-312028-10-31
NCT06748053A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled AsthmaRECRUITING2026-07-15PHASE22025-02-102027-01-14
NCT06387342Namodenoson Treatment of Advanced Pancreatic CancerRECRUITING2026-07-15PHASE22024-11-102026-12-15
NCT06317311A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerACTIVE_NOT_RECRUITING2026-07-15PHASE22024-05-072027-08-31
NCT06881251A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)RECRUITING2026-07-15PHASE22025-02-262026-08-14
NCT06548100A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)ACTIVE_NOT_RECRUITING2026-07-14PHASE32024-12-162026-11-03
NCT06188507A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy ParticipantsSUSPENDED2026-07-14PHASE12024-01-122026-07-14
NCT06832618A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic DermatitisRECRUITING2026-07-13PHASE32025-06-172028-05-18
NCT05630352A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and ChildrenWITHDRAWN2026-07-13PHASE12025-01-062026-07-13
NCT05039840Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusRECRUITING2026-07-10PHASE22021-11-102026-10-02
NCT06112743A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyACTIVE_NOT_RECRUITING2026-07-09PHASE42024-01-242026-07-09
NCT06851858Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistRECRUITING2026-07-08PHASE22025-03-122026-07-08
NCT06194448To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsACTIVE_NOT_RECRUITING2026-07-07PHASE22024-04-212027-07-07
NCT04380636Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)ACTIVE_NOT_RECRUITING2026-07-06PHASE32020-07-062027-02-15
NCT06088199A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque PsoriasisRECRUITING2026-07-06PHASE32023-10-242026-07-06
NCT06864169A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)RECRUITING2026-07-06PHASE22025-04-012029-01-04
NCT04784715Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)ACTIVE_NOT_RECRUITING2026-07-06PHASE32021-04-262029-12-30
NCT06567782A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon CancerRECRUITING2026-07-06PHASE22025-02-172028-06-15
NCT06122779Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)RECRUITING2026-07-03PHASE22023-11-072026-07-03
NCT06843408A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHDRECRUITING2026-07-03PHASE1, PHASE22025-06-252027-12-31
NCT05702229Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRECRUITING2026-07-03PHASE22023-01-162027-07-01
NCT05966480Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusACTIVE_NOT_RECRUITING2026-07-01PHASE22023-06-262027-09-01
NCT06693895A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of AgeRECRUITING2026-07-01PHASE32024-11-262026-11-23
NCT04919980TVMR With the Innovalve System Trial - Early Feasibility StudyRECRUITING2026-07-01NA2022-09-012031-07-01
NCT05479812Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsRECRUITING2026-07-01PHASE12022-05-202026-07-31
NCT06617429Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)ACTIVE_NOT_RECRUITING2026-07PHASE32024-12-032027-11
NCT03891446Long-term Safety and Efficacy Extension Trial of Bimatoprost SRACTIVE_NOT_RECRUITING2026-07PHASE32019-03-272026-08
NCT06848348Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainRECRUITING2026-07PHASE22025-02-212026-08
NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeRECRUITING2026-07PHASE32024-05-282027-07
NCT04544267Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeSUSPENDED2026-07PHASE32020-09-152026-07
NCT06750432PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)RECRUITING2026-07PHASE12024-12-132026-12
NCT06921759A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot DermatitisRECRUITING2026-07PHASE32025-04-212026-09
NCT05839730Fast Induced Remodeling in Heart Failure With Preserved Ejection FractionRECRUITING2026-07NA2024-09-112027-07
NCT06606106A Study of LY3537031 in Overweight, Obese, and Healthy ParticipantsRECRUITING2026-07PHASE12024-09-052026-07
NCT06783621A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica ProductsRECRUITING2026-07PHASE42025-01-162026-07
NCT06101329Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)ACTIVE_NOT_RECRUITING2026-07PHASE22023-11-172028-01
NCT05082571Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney DiseaseWITHDRAWN2026-07PHASE32025-012026-10
NCT07054684Study of BHV-1400 in IgA NephropathyRECRUITING2026-07PHASE12025-07-302026-07
NCT06566092Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsRECRUITING2026-07PHASE12024-03-282028-07
NCT06689839Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRNOT_YET_RECRUITING2026-07NA2025-03-012026-10
NCT05720117Study of PYX-201 in Solid TumorsRECRUITING2026-07PHASE12023-03-142027-05
NCT06959121CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial FibrillationNOT_YET_RECRUITING2026-07NA2025-072027-01
NCT07092813Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in AdolescentsNOT_YET_RECRUITING2026-07PHASE12025-092026-07
NCT05082584Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating AgentsWITHDRAWN2026-07PHASE32025-012026-10
NCT06521463SIMPLAAFY Clinical TrialRECRUITING2026-07NA2024-10-012027-01
NCT07123727A Study to Examine Anktiva for the Treatment of COVID-19.RECRUITING2026-07PHASE22025-092026-07
NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineRECRUITING2026-07PHASE32025-07-092027-07
NCT06937203Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes MellitusRECRUITING2026-07PHASE1, PHASE22025-05-072026-07
NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsRECRUITING2026-07PHASE32024-06-062026-08
NCT07158437Phase 1 Study of SL-325 in Healthy VolunteersRECRUITING2026-07PHASE12025-092026-07
NCT06481891A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyRECRUITING2026-07PHASE32024-09-242026-08
NCT05005403Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or BevacizumabRECRUITING2026-07PHASE12021-11-012027-06
NCT06188585Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal BleedingRECRUITING2026-07NA2024-06-212026-08
NCT06425159A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresRECRUITING2026-07PHASE2, PHASE32024-06-202027-07
NCT07155668A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)RECRUITING2026-07PHASE32025-07-012026-11
NCT06562907Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)RECRUITING2026-07PHASE12024-08-282026-07
NCT05650879ELVN-002 in HER2 Mutant Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-07PHASE12023-03-202026-07
NCT03519945A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)RECRUITING2026-07PHASE32018-07-182027-12
NCT03118505A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal ConditionsACTIVE_NOT_RECRUITING2026-07NA2017-06-292026-12
NCT06470451Confirmatory Study of Topical HyBryteâ„¢ vs. Placebo for the Treatment of CTCLRECRUITING2026-07PHASE32025-01-072026-10
NCT07108153Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaNOT_YET_RECRUITING2026-07PHASE22025-102026-07
NCT06084481Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400RECRUITING2026-07PHASE12023-11-092026-07
NCT05552755Evaluate REC-4881 in Patients With FAPRECRUITING2026-07PHASE1, PHASE22023-07-102026-07
NCT07159828A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid TumorsRECRUITING2026-07PHASE12025-09-152027-05-15
NCT04184050Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)ACTIVE_NOT_RECRUITING2026-06-30PHASE12020-04-132026-06-30
NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyRECRUITING2026-06-30PHASE22024-09-172028-03-31
NCT03706833Edwards PASCAL CLASP IID/IIF Pivotal Clinical TrialRECRUITING2026-06-30NA2018-11-302031-06-30
NCT06606847A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)ACTIVE_NOT_RECRUITING2026-06-30PHASE22024-09-242027-06-30
NCT04150497Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)RECRUITING2026-06-30PHASE1, PHASE22019-10-142026-06-30
NCT05221840A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-06-30PHASE32022-02-072030-07-02
NCT06851806Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) DiseaseNOT_YET_RECRUITING2026-06-30NA2025-08-302026-06-30
NCT06637423A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)RECRUITING2026-06-30PHASE1, PHASE22024-12-202028-07-31
NCT05825365Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, Phaseâ…¡, Double-Blinded, Placebo-Controlled StudyWITHDRAWN2026-06-30PHASE22023-08-312026-06-30
NCT06049212Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)RECRUITING2026-06-30PHASE12023-10-262027-01-29
NCT04939610A Study of 177Lu-FAP-2286 in Advanced Solid TumorsRECRUITING2026-06-30PHASE1, PHASE22021-07-302028-06-30
NCT04524000Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast CancerACTIVE_NOT_RECRUITING2026-06-30PHASE22021-01-082026-07-31
NCT04925479Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaRECRUITING2026-06-30PHASE1, PHASE22021-12-272031-11-01
NCT06016738OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerRECRUITING2026-06-30PHASE32023-11-162027-09-30
NCT04855656Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsRECRUITING2026-06-30PHASE12021-04-302026-12-31
NCT05911295Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2RECRUITING2026-06-30PHASE32023-09-222029-04-30
NCT05818683A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate CancerRECRUITING2026-06-30PHASE12023-04-262027-09-01
NCT05511922PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 TrialACTIVE_NOT_RECRUITING2026-06-30PHASE32022-10-242026-06-30
NCT04406727UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 InfectionNOT_YET_RECRUITING2026-06-30PHASE32023-12-012026-06-30
NCT05701800A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of AgeACTIVE_NOT_RECRUITING2026-06-30PHASE1, PHASE22023-01-232026-06-30
NCT05920356A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RECRUITING2026-06-30PHASE32023-11-162031-06-30
NCT05505916An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)ACTIVE_NOT_RECRUITING2026-06-30PHASE32022-10-242026-06-30
NCT05208944THIO Sequenced With Cemiplimab in Advanced NSCLCRECRUITING2026-06-30PHASE22022-06-082026-12-31
NCT03742895Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)ACTIVE_NOT_RECRUITING2026-06-30PHASE22018-12-122026-06-30
NCT04925024Evaluation of Lomecel-Bâ„¢ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.ACTIVE_NOT_RECRUITING2026-06-30PHASE22021-06-252026-08-31
NCT06308120A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENBRECRUITING2026-06-30NA2024-03-202026-09-30
NCT04892173JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRECRUITING2026-06-30PHASE32022-01-042027-12-31
NCT06407934A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisRECRUITING2026-06-29PHASE32024-05-082027-04-05
NCT07074327Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy ParticipantsRECRUITING2026-06-29PHASE12025-07-112026-07-04
NCT03813407An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRECRUITING2026-06-29PHASE32019-04-022026-06-29
NCT05440708A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaRECRUITING2026-06-29PHASE1, PHASE22023-03-232027-06-28
NCT04906460Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)RECRUITING2026-06-27PHASE1, PHASE22021-09-282027-04-24
NCT06785012A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderRECRUITING2026-06-26PHASE22024-12-262026-06-26
NCT05265273A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisRECRUITING2026-06-26PHASE2, PHASE32022-07-202026-06-26
NCT05021835ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationACTIVE_NOT_RECRUITING2026-06-26PHASE32021-08-302026-06-26
NCT06372925Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial InfarctionRECRUITING2026-06-24PHASE42024-07-122026-06-24
NCT03975829Pediatric Long-Term Follow-up and Rollover StudyACTIVE_NOT_RECRUITING2026-06-23PHASE42019-11-042026-07-23
NCT07034690Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With DyslipidemiaNOT_YET_RECRUITING2026-06-23PHASE42025-06-302027-06-30
NCT06698042A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)RECRUITING2026-06-22PHASE32024-11-212030-02-11
NCT04640025A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of ItacitinibACTIVE_NOT_RECRUITING2026-06-22PHASE22021-03-102026-06-22
NCT05624450Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRECRUITING2026-06-19PHASE32022-12-132026-06-19
NCT06028230A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaACTIVE_NOT_RECRUITING2026-06-19PHASE22023-09-292026-07-17
NCT06104124A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease ActivityACTIVE_NOT_RECRUITING2026-06-18PHASE32024-01-242026-08-19
NCT07105722A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of AgeRECRUITING2026-06-18PHASE12025-08-122026-06-18
NCT06862791A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs AloneACTIVE_NOT_RECRUITING2026-06-18PHASE22025-02-182026-06-18
NCT05600777A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughRECRUITING2026-06-17PHASE32022-12-052027-03-23
NCT06188520A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid TumorsRECRUITING2026-06-17PHASE1, PHASE22023-12-052026-06-17
NCT05731128A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))RECRUITING2026-06-17PHASE22023-01-122027-03-24
NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenRECRUITING2026-06-16PHASE2, PHASE32022-09-232026-06-16
NCT04185883Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)RECRUITING2026-06-16PHASE12019-12-172027-12-05
NCT04208178Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationACTIVE_NOT_RECRUITING2026-06-16PHASE32020-07-162026-06-16
NCT05742802Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).RECRUITING2026-06-16PHASE32023-03-062026-08-17
NCT05851443A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaRECRUITING2026-06-15PHASE22023-07-112027-01-31
NCT07153146Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.NOT_YET_RECRUITING2026-06-15PHASE12025-09-082026-06-15
NCT05424822A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)ACTIVE_NOT_RECRUITING2026-06-12PHASE12022-08-182027-07-30
NCT07045701FMXIN002 in Patients at Risk of AnaphylaxisENROLLING_BY_INVITATION2026-06-12PHASE2, PHASE32025-06-122026-07-12
NCT06450197Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseRECRUITING2026-06-12PHASE22024-08-282027-08-02
NCT05714969A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)RECRUITING2026-06-11PHASE22023-03-212026-06-11
NCT06417814A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerRECRUITING2026-06-11PHASE32024-10-042028-05-29
NCT05750628Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRECRUITING2026-06-09PHASE22024-01-232026-06-23
NCT06821750A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2026-06-09PHASE12025-02-112026-06-09
NCT06970405Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal WomenWITHDRAWN2026-06-08PHASE12025-05-292026-06-08
NCT06299111A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)RECRUITING2026-06-08PHASE22024-09-202026-06-08
NCT06384820Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)WITHDRAWN2026-06-08PHASE22024-11-142030-05-06
NCT06004661Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal FunctionRECRUITING2026-06-05PHASE22024-04-042026-08-04
NCT06973291A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisRECRUITING2026-06-05PHASE32025-07-092026-07-03
NCT03584165Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis PigmentosaENROLLING_BY_INVITATION2026-06-04PHASE32018-06-042026-06-04
NCT06965465A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2026-06-04PHASE12025-06-202026-06-04
NCT04077463A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-06-03PHASE12019-09-042026-06-03
NCT06312020A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeRECRUITING2026-06-02PHASE22024-05-092027-02-09
NCT06534411A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothACTIVE_NOT_RECRUITING2026-06-02PHASE32024-11-052026-07-14